Laurie Glimcher is to be the next CEO of the Dana-Farber Cancer Institute, and she turned down the opportunity to be the first female dean of Harvard Medical School to do so, Stat News reports.

"I felt I would have more autonomy at Dana-Farber, which is an institution that stands on its own," she tells Stat News. She will be the first woman to run the cancer center when she takes over for Edward Benz, who is stepping down in January.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.